Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for P... (rphan gout population. I look forward to...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase

Date:11/19/2008

rphan gout population. I look forward to working with the Board, the BLA Oversight Committee and the rest of the Savient team to realize this market opportunity."

The company also announced that Philip K. Yachmetz will now serve as Senior Vice President, General Counsel. Since joining the company in May 2004, Mr. Yachmetz has served in various other capacities including Chief Business Officer, Corporate Strategy and Corporate Secretary.

WEBCAST

Savient will conduct a live webcast to discuss the formation of the BLA Oversight Committee and the other corporate changes the Company announced today at 10:00 a.m. EST. Participating on the webcast will be Stephen O. Jaeger, Chairman of the Board, and Paul Hamelin, President. Both the live and archived webcast can be accessed from the Investor Relations page of Savient's website at http://www.savient.com. A digital recording of the webcast will be available within one hour following the conclusion of the call and will be available for 14 days. To access the recording, use the Dial-In Number and the Conference ID listed below.

Dial: (800) 642-1687 (domestic) or (706)645-9291 (international)

Conf ID: 74211270

About Lee S. Simon, M.D.

Dr. Simon has been a director of Savient since May 2006 and is a member of the Nominating and Corporate Governance Committee. Since 1996, Dr. Simon has served as a member of the staff of Beth Israel Deaconess Medical Center. He is currently a consultant to the pharmaceutical industry serving to provide support for regulatory issues. Since 2003, Dr. Simon has been an Associate Clinical Professor of Medicine at Harvard Medical School. From 2001 to 2003, Dr. Simon was the Director of the Analgesic, Anti-Inflammatory, Ophthalmologic Drug Products Division of the U.S. Food and Drug Administration. Fr
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
2. Richard Greco Joins Mediware Board
3. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
4. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
5. Montana Health Care Leader Elected Board Chair of National Association
6. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
9. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
10. Patient Safety Authority Board of Directors Names Infection Advisory Panel
11. William Moore Appointed to IRIDEX Board of Directors

Post Your Comments:

[0] Soy Beneficial for Breast Cancer Survivors: Study [1] Researchers Use New Techniques to Assess PTSD [0] Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)[1] Patient Safety Organization (PSO) Participation: What Every Provider Needs to Know [1] Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)

Other Medicine News:Health News: FreePatentsOnline Launches the CitePatents Program : Making it Easy for Bloggers and Journalists to Reference Patents, and Add Patent Search to Websites 2 Health News:Miami Physician Sentenced to 30 Years in Prison for $11 Million Medicare Fraud Scheme 2 Health News:Miami Physician Sentenced to 30 Years in Prison for $11 Million Medicare Fraud Scheme 3 Health News:Miami Physician Sentenced to 30 Years in Prison for $11 Million Medicare Fraud Scheme 4 Health News:New Report: Public Insurance Option Needed to Provide Affordable, Quality Health Coverage 2 Health News:New Report: Public Insurance Option Needed to Provide Affordable, Quality Health Coverage 3 Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 2 Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 3 Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 4

FreePatentsOnline Launches the CitePatents Program : Making it Easy for Bloggers and Journalists to Reference Patents, and Add Patent Search to Websites Miami Physician Sentenced to 30 Years in Prison for $11 Million Medicare Fraud Scheme Rural/Metro Employee Shareholders Voice Concerns At Company's Annual Meeting New Report: Public Insurance Option Needed to Provide Affordable, Quality Health Coverage The Biggest Loser Milks a Big Win Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team

Breaking Medicine Technology:Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System 2 AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2 AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3 Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2 Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3 Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4 Imagenetix Inc Announces Interview With Bloomberg Radio 13589 1 Imagenetix Inc Announces Interview With Bloomberg Radio 13589 2 New Data Supports ConvaTec Negative Pressure Wound Therapy 4855 1 New Data Supports ConvaTec Negative Pressure Wound Therapy 4855 2 New Data Supports ConvaTec Negative Pressure Wound Therapy 4855 3 Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 1 Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 2 Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 3 Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 4

[0] Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System [0] AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa [0] Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation

Other Medicine Technology:Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 2 Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 3 Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 4 Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 5 Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting 2 Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting 3 Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting 4

Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data,From Nerve Regeneration Program at American Society for Neural,Therapy and Repair Meeting

Medicine Products:

Danker Laboratories, Inc.Bambi Database Distribution Center Optizone Enterprise

Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for P...(rphan gout population. I look forward to...),Health